A Traditional Medicinal Root Reveals Antioxidant and Anti-Inflammatory Potential in New Study

A root long used in traditional East Asian medicine is now giving up its chemical secrets to modern analytical science. Researchers at Kyungpook National University, working with a collaborator at the University of California, Davis, have carried out an integrated investigation of the lipophilic fraction of Liriope platyphylla root, a plant known in Korea and China as a tonic herb. Combining gas chromatography–mass spectrometry, network pharmacology, molecular docking, and laboratory assays on immune cells, the team mapped the chemical inventory of the extract and tested whether it can shield cells from oxidative stress and inflammation. Their findings, published in Food Science and Biotechnology, offer preliminary but encouraging evidence that this underexplored fraction of a familiar medicinal plant may possess meaningful bioactivity.

The study began with chemical profiling. Using gas chromatography coupled to mass spectrometry, the researchers tentatively identified 63 distinct compounds in the lipophilic fraction of Liriope platyphylla root, abbreviated LLPR. This fat-soluble portion of the root contains molecules that differ from the polar steroids and polysaccharides typically emphasized in earlier work on the genus. The tentatively identified constituents include sterols and other lipophilic compounds such as stigmasterol, beta-sitosterol, and cycloartenol, molecules that have attracted attention in the pharmacological literature for their antioxidant and anti-inflammatory properties in their own right. By carefully cataloguing what the fraction actually contains, the team established a rational foundation for asking which biological targets those molecules might engage.

To move from a compound list to a mechanistic hypothesis, the researchers turned to network pharmacology, a computational strategy that maps the relationships between bioactive molecules, their predicted protein targets, and disease-associated biological pathways. When the 63 compounds were connected to known target proteins, a coherent picture emerged: LLPR constituents were predicted to associate with proteins central to the body’s oxidative stress and inflammatory responses. Among the most prominent hubs were NFE2L2, the gene encoding the transcription factor Nrf2; KEAP1, the sensor protein that holds Nrf2 in check; TLR4, a Toll-like receptor that triggers inflammatory signaling; NFKB1, a component of the NF-kappaB transcription complex; and PTGS2, the gene for cyclooxygenase-2, a key enzyme in inflammatory prostaglandin production.

These predicted targets are not arbitrary. The Nrf2-KEAP1 axis is widely regarded as the master regulatory system for cellular antioxidant defense. Under normal conditions, KEAP1 binds Nrf2 and directs it for degradation. When oxidative stress modifies KEAP1, Nrf2 escapes, accumulates, and travels to the nucleus, where it switches on a battery of cytoprotective genes, including the antioxidant enzymes catalase, glutathione peroxidase, and superoxide dismutase, as well as heme oxygenase-1, an enzyme with well-documented anti-inflammatory and antioxidant effects. Meanwhile, the TLR4 and NF-kappaB pathways represent the inflammatory side of the equation: activation of TLR4 by bacterial products such as lipopolysaccharide drives NF-kappaB into the nucleus, where it induces genes for inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines such as interleukin-1beta. A natural product fraction capable of modulating both arms of this network would, in principle, blunt the damaging amplification loop that links oxidative stress to chronic inflammation.

To test whether the predicted interactions were structurally plausible, the team performed molecular docking simulations. Docking computationally fits small molecules into the binding pockets of target proteins and scores how favorably they nestle there. The results suggested that LLPR constituents could bind to the oxidative stress- and inflammation-related proteins identified by the network analysis, lending structural credibility to the computational predictions. The authors are careful to stress, however, that docking and network pharmacology generate hypotheses rather than proof. The predicted molecular associations, they note, require direct mechanistic validation before any definitive claims about mechanism can be made. That candor distinguishes the study from less rigorous explorations in this field and sets a clear agenda for follow-up experiments.

The laboratory phase of the work proceeded in two stages. First, the researchers assessed the intrinsic antioxidant capacity of LLPR using cell-free assays, which measure a substance’s ability to neutralize reactive radicals in a test tube without the complication of living cells. LLPR exhibited measurable antioxidant capacity in these assays, confirming that at least part of its activity can be attributed to direct radical-scavenging chemistry, likely contributed by its lipophilic constituents.

The more biologically revealing experiments used RAW 264.7 macrophages, a widely used mouse immune cell line that models the inflammatory behavior of macrophages in tissue. The researchers stimulated the cells with lipopolysaccharide, a component of the outer membrane of Gram-negative bacteria that provokes a robust inflammatory and oxidative response, and then treated the cells with LLPR. The results were striking. LLPR restored the expression of catalase, an antioxidant enzyme that lipopolysaccharide had suppressed, and partially increased the expression of glutathione peroxidase and superoxide dismutase, two other first-line antioxidant enzymes. It also enhanced the expression of heme oxygenase-1, the inducible cytoprotective enzyme whose upregulation is a hallmark of Nrf2 pathway activation. Functionally, these changes mattered: LLPR reduced the accumulation of intracellular reactive oxygen species in the stressed macrophages, indicating that the enzyme-level changes translated into genuine protection against oxidative damage.

The anti-inflammatory side of the evaluation was equally encouraging. In the lipopolysaccharide-stimulated macrophages, LLPR attenuated the production of nitric oxide, a reactive molecule that contributes to inflammatory tissue damage, and reduced the expression of inducible nitric oxide synthase, the enzyme responsible for generating it. The fraction also lowered the expression of cyclooxygenase-2, the inducible enzyme that drives prostaglandin synthesis and is the target of common anti-inflammatory drugs, and it reduced levels of interleukin-1beta, a potent pro-inflammatory cytokine implicated in a broad range of inflammatory diseases. Taken together, the cellular data show that LLPR can simultaneously reinforce antioxidant defenses and restrain inflammatory signaling in a well-established model of inflammation, consistent with the dual action predicted by the computational analyses.

The broader significance of the work lies in both its methodology and its implications. Scientifically, the study exemplifies an increasingly popular integrated pipeline in natural product research: chemical profiling identifies what is in an extract, network pharmacology predicts what those constituents could do in the body, molecular docking tests whether the predictions are structurally feasible, and in vitro assays verify whether the predicted bioactivity is real in living cells. This chain of evidence is stronger than any single approach alone, and it offers a template for rapidly screening traditional medicinal plants whose complex chemistry has resisted conventional reductionist analysis. For Liriope platyphylla specifically, the study extends previous research, which has reported activities ranging from nerve growth factor induction to relief of atopic dermatitis symptoms and improved gastrointestinal motility, by systematically characterizing a lipophilic fraction that earlier work had largely overlooked.

The authors and observers alike caution that these are early findings. All of the biological results come from cell culture, and the cell-free and cellular assays, while informative, cannot capture the absorption, metabolism, distribution, and toxicity questions that determine whether a plant fraction will have useful effects in a living organism. The computational predictions linking LLPR constituents to Nrf2, KEAP1, TLR4, NF-kappaB, and cyclooxygenase-2 remain to be confirmed with direct biochemical experiments, such as binding assays and pathway-specific studies in cells and animal models. Human relevance is even further away. Nevertheless, the study provides a credible preliminary case that the lipophilic fraction of Liriope platyphylla root harbors antioxidant and anti-inflammatory activity, and it identifies specific molecular targets that future research can interrogate. For a root that traditional medicine has valued for centuries, the convergence of ancient use and modern systems-level analysis is a compelling signal that there may be real pharmacology waiting to be understood, one carefully validated mechanism at a time.

Subject of Research: Antioxidant and anti-inflammatory potential of a lipophilic fraction from Liriope platyphylla root

Article Title: Integrated chemical profiling, network pharmacology, molecular docking, and in vitro evaluation of the antioxidant and anti-inflammatory potential of a lipophilic fraction from Liriope platyphylla root

Article References: Truong, V.-L., Rarison, R. H. G., Bang, J.-H., Bae, Y.-J., Nitin, N., & Jeong, W.-S. (2026). Integrated chemical profiling, network pharmacology, molecular docking, and in vitro evaluation of the antioxidant and anti-inflammatory potential of a lipophilic fraction from Liriope platyphylla root. Food Science and Biotechnology. https://doi.org/10.1007/s10068-026-02291-w

Image Credits: AI Generated

DOI: 10.1007/s10068-026-02291-w

Keywords: Liriope platyphylla, antioxidant, anti-inflammatory, lipophilic fraction, network pharmacology, molecular docking, gas chromatography-mass spectrometry, Nrf2, NF-kappaB, macrophages, oxidative stress, natural products